Exosome RNA Exosome RNA Research & Industry News
An intracellular delivery system for CRISPR/Cas9 is crucial for its application as a therapeutic genome editing technology in a broad range of diseases. Current vehicles carrying CRISPR/Cas9 limit in vivo delivery because of low tolerance and immunogenicity; thus, the in ...
Read More »Cancer-derived exosomes as a delivery platform of CRISPR/Cas9
